Form D · Biotechnology
ENDOCYTE INC
West Lafayette, IN · CIK 0001235007
Offering snapshot reported Dec 23, 2010 · SEC filing
- Reported sold
- $8.1M Offering amount: $15M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 14, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 23, 2010 | Initial | $8,100,000 | No comparison | 3 | SEC filing |
| Oct 26, 2009 | Amendment | $26,645,523 | $7,740,958vs Aug 7, 2009 | 28 | SEC filing |
| Aug 7, 2009 | Initial | $18,904,565 | No comparison | 25 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-152417
Source: Form D, filed Dec 23, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John C. Aplin | Director |
| Douglas B. Bailey | Director |
| Keith Brauer | Director |
| John C. Clawson | Director |
| Jack Clawson | Director |
| P. Ron Ellis | Director, Executive |
| Ann F. Hanham | Director |
| Philip S. Low | Director |
| Fred A. Middleton | Director |
| James S. Shannon | Director |
| Mike Sherman | Executive |
| Michael A. Sherman | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3000 Kent Ave Ste A1 100
West Lafayette, IN, 47906
West Lafayette, IN, 47906